Capivasertib Uses, Dosage, Side Effects and more
Capivasertib has been investigated for the treatment of Metastatic Breast Cancer.
| Attribute | Details |
|---|---|
| Trade Name | Capivasertib |
| Generic | Capivasertib |
| Capivasertib Other Names | Capivasertib, Capivasertibum |
| Type | |
| Formula | C21H25ClN6O2 |
| Weight | Average: 428.915 Monoisotopic: 428.172751781 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
